ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,759.42
      0.24%
      US Tech 100
      19,557.60
      -0.11%
      Dow Jones
      42,520.01
      0.82%
      Brent Oil
      71.235
      0.40%
      Bitcoin
      66,323.98
      1.75%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Redhill Biopharma Ltd (RDHL)

      7. Redhill Biopharma Ltd (RDHL) News

      RDHL

      Redhill Biopharma (RDHL)

      Redhill Biopharma Ltd
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:RDHL
      DateTimeSourceHeadlineSymbolCompany
      09/18/20249:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RDHLRedhill Biopharma Ltd
      09/17/20249:13AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RDHLRedhill Biopharma Ltd
      09/09/20247:04AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RDHLRedhill Biopharma Ltd
      09/09/20247:00AMPR Newswire (US)RedHill's Talicia® Listed as First-Line Choice for H. pylori in New American College of Gastroenterology GuidelinesNASDAQ:RDHLRedhill Biopharma Ltd
      09/05/20248:30AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RDHLRedhill Biopharma Ltd
      09/05/20247:05AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RDHLRedhill Biopharma Ltd
      09/05/20247:00AMPR Newswire (US)RedHill Biopharma Regains Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:RDHLRedhill Biopharma Ltd
      09/03/20247:03AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RDHLRedhill Biopharma Ltd
      09/03/20247:00AMPR Newswire (US)New Peer-Reviewed Publication of Opaganib Phase 2/3 Data Shows 62% Reduction in COVID-19 MortalityNASDAQ:RDHLRedhill Biopharma Ltd
      08/29/20247:07AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RDHLRedhill Biopharma Ltd
      08/29/20247:00AMPR Newswire (US)RedHill Biopharma Announces First Half 2024 Business HighlightsNASDAQ:RDHLRedhill Biopharma Ltd
      08/26/20247:02AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RDHLRedhill Biopharma Ltd
      08/26/20247:00AMPR Newswire (US)RedHill's Opaganib Granted Orphan Drug Designation by the FDA for Childhood Cancer, NeuroblastomaNASDAQ:RDHLRedhill Biopharma Ltd
      08/21/20247:04AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RDHLRedhill Biopharma Ltd
      08/21/20247:00AMPR Newswire (US)Talicia® Launched in the United Arab EmiratesNASDAQ:RDHLRedhill Biopharma Ltd
      08/20/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RDHLRedhill Biopharma Ltd
      08/19/20247:01AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RDHLRedhill Biopharma Ltd
      08/19/20247:00AMPR Newswire (US)RedHill Announces Positive Obesity and Diabetes Results with OpaganibNASDAQ:RDHLRedhill Biopharma Ltd
      08/16/20247:13AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RDHLRedhill Biopharma Ltd
      08/16/20247:00AMPR Newswire (US)RedHill Biopharma Announces Plan to Implement ADS Ratio ChangeNASDAQ:RDHLRedhill Biopharma Ltd
      08/13/20241:37PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:RDHLRedhill Biopharma Ltd
      08/13/20248:35AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RDHLRedhill Biopharma Ltd
      08/09/20247:01AMEdgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:RDHLRedhill Biopharma Ltd
      08/07/20244:43PMEdgar (US Regulatory)Form SCHEDULE 13D - General Statement of Acquisition of Beneficial OwnershipNASDAQ:RDHLRedhill Biopharma Ltd
      08/07/20249:51AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:RDHLRedhill Biopharma Ltd
      08/06/20247:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RDHLRedhill Biopharma Ltd
      08/01/20247:05AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RDHLRedhill Biopharma Ltd
      08/01/20247:00AMPR Newswire (US)Newly Published Positive Phase 3 Data Demonstrates 64% Increased Efficacy with RedHill's RHB-104 in Crohn's DiseaseNASDAQ:RDHLRedhill Biopharma Ltd
      07/22/20247:04AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RDHLRedhill Biopharma Ltd
      07/22/20247:00AMPR Newswire (US)RedHill Biopharma Strengthens Cash Balance, Settles Obligations and Removes Talicia® LienNASDAQ:RDHLRedhill Biopharma Ltd
       Showing the most relevant articles for your search:NASDAQ:RDHL